announced that the Data Monitoring Committee (DMC) has reviewed the open-label arm of its Phase 3 sunRIZE study for the treatment of congenital hyperinsulinism with ersodetug in infants under one ...
Open-label arm (infant participants < 1 year old) has been recently reviewed by a Data Monitoring Committee (DMC) and target drug ...
Open-label arm (infant participants DMC approved enrollment of infants into the double-blind portion of the study sunRIZE enrollment completion expected in Q2 2025, subject to outcomes from upcoming ...
LUCY Letby’s conviction risks being thrown wide open after medical experts deemed evidence used to convict her “unsafe”. Last ...
A coroner has voiced concerns about how long it took for a 999 call to be answered and an ambulance to arrive when a newborn ...
This is shown by the largest survey ... Infant Mortality Rates Declining, but Sudden Unexpected Infant Death Is on the Rise Jan. 27, 2025 — Infant mortality in the United States decreased by 24. ...
Shares of Rezolute RZLT have rallied 30.8% in the past six months against the industry’s decline of 4.1%, driven by investor ...
Rezolute (RZLT) announced outcomes from an independent Data Monitoring Committee, DMC, review of the open label arm, OLA, portion of the ...
Q: My baby is small but my pediatric provider says she is "following the curve" so he is not worried. What does that mean? I'm still worried! A. If your baby is "following the curve" of the growth ...
Neonatal skin antisepsis with alcohol-based compared to aqueous 2% chlorhexidine, used in moderate preterm infants or extremely preterm infants after the first week of life, is safe and may be ...
It mainly affects infants and children – putting them ... unmet medical need for newborns and children with congenital hyperinsulinism who have either no or very limited treatment options ...
Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by ...